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Visual functionNeuroglobin is a member of the globin superfamily expressed in vertebrate brain and retina. The protein is
thought to be involved in neuronal protection from hypoxia or oxidative stress and could represent a key
element of Alzheimer disease pathogenesis. Our aim was to determine whether neuroglobin could be directly
associated with mitochondrial metabolism and integrity. We identiﬁed three different forms of neuroglobin
in the retina, varying in their apparent molecular masses; all forms are abundant in mitochondrial fractions.
This indicates that a signiﬁcant fraction of the protein localizes within the organelle either in the matrix or in
the matrix side of the inner membrane. Since neuroglobin was especially abundant in the ganglion cell layer,
we transduced retinal ganglion cells with an anti-neuroglobin short hairpin RNA using in vivo electroporation.
Neuroglobin knockdown leads to reduced activities of respiratory chain complexes I and III, degeneration of
retinal ganglion cells, and impairment of visual function. The deleterious effect on cell survival was conﬁrmed
in primary retinal ganglion cells subjected to inhibition of neuroglobin expression. Hence, neuroglobin should
be considered as a novel mitochondrial protein involved in respiratory chain function which is essential for
retinal ganglion cell integrity.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Neuroglobin (Ngb), the ﬁrst “globin of nerve cells” identiﬁed in ver-
tebrates as amember of the globin superfamily, is expressed in cerebral
cortical regions and the cerebellum [1]. These areas show vulnerability
to neurodegenerative diseases; interestingly in 2010 a follow-up study
reported of the genetic association for selected candidate genes in the
14q region that provides signiﬁcant evidence for neuroglobin gene
(NGB), and NGB mRNA expression proﬁle involvement in Alzheimer
disease (AD) [2]. Additionally, the involvement of Ngb in neuronal
degeneration has been extensively studied in rodent brain during
aging [3] and in mouse models of AD, such as Tg2576 and TgMapt
mice. In these mice the level of Ngb was signiﬁcantly reduced and neg-
atively correlated with phosphorylated tau and NGB overexpressionis France. Tel.: +33 1 53 46 25
Debrinski).
rights reserved.prevents tau from hyperphosphorylation [4]. It is well known that
neuroﬁbrillary tangle (aggregates of hyperphosphorylated tau) is high-
ly correlated with the degree of dementia in AD patients [5]. It has also
been demonstrated that Ngb could alleviate oxidative stress, eliminate
reactive oxidative species [6–8], preserve mitochondrial function and
resist apoptosis [9,10], all of which participate in the AD pathogenesis;
by consequence Ngb could be a promising therapeutic target for
AD in particular or more generally for neuronal degeneration
pathologies.
Several reports indicate a putative localization of Ngb in the mito-
chondrial compartment or its vicinity in the brain [11–13]. NGB is
expressed in the anterior and posterior segments of the eye including
corneal epithelium, non-pigmented epithelial cells, photoreceptor
inner segments, plexiform layers, and ganglion cell layer (GCL)
[14–16]. Therefore, we decided to study the in vivo impact of NGB
knockdown in rat retinal ganglion cells (RGCs), since RGC loss is
responsible for optic neuropathies with mitochondrial origin [17].
Recently, it has been shown that the constitutive up-regulation of
NGB promoted RGC survival in a transgenic mouse model of hyper-
tensive glaucoma [18]. We demonstrate here that Ngb and ATP
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RGC primary cultures. Subsequently, we showed in rat retinas that
three forms of Ngb, considering their apparent molecular masses,
coexist in mitochondrial fractions; these forms are resistant to prote-
olysis indicating that a substantial amount of all three Ngb forms is
imported into the organelle where they localize in the matrix or in
close proximity to the inner membrane.We used the small interfering
RNA (siRNA) method to knockdown the expression of NGB in primary
rat RGC cultures and we observed a decrease in cell survival indicat-
ing that endogenous Ngb is required for cell viability. The in vivo
knockdown of NGB expression by subjecting to electroporation
(ELP) [19,20] rat eyes after intravitreal administration of short harpin
(sh) anti-Ngb RNA was effective in reducing NGB expression. NGB
knockdown caused deleterious effects on retinal structure and
function: (1) nerve ﬁber density was decreased; (2) the overall
number of RGCs was reduced; (3) the optic nerves exhibited a
signiﬁcant defect in respiratory chain complex I and III activities;
and (4) visual function was impaired.
Hence, our data show a direct functional link between Ngb and mi-
tochondrial integrity in vivo. Indeed, its subcellular localization in the
organelle and its requirement for respiratory chain function clearly
delineate one of its cellular functions that are crucial for RGC survival.2. Materials and methods
2.1. Animals
Male Long Evans rats were used (Janvier, France). They were
housed two per cage in a temperature-controlled environment, 12 h
light/dark cycle. All animal studies were conducted in accordance
with the guidelines issued by the French Ministry of Agriculture and
the Veterinarian Department of Paris (Permit number DF/DF_
2010_PA1000298), the French Ministry of Research (Approval
number 5575) and the ethics committees of the University Paris 6
and INSERM (Authorization number 75-1710).2.2. siRNA and shRNA plasmid construction
Anti-Ngb siRNA (5′GUGAGUCCCUGCUCUACAU[dt]3′) or unspeciﬁc
scrambled siRNA (5′GCCACACGAUUGCUGUCUU[dt]3′) was synthesized
by Sigma-Aldrich. Rat RGCs were transfected with siRNAs (50 nM) and
HiPerfect reagent (Qiagen, Valencia, CA) as recommended by the
manufacturer. Anti-Ngb shRNA and anti-scrambled shRNA expression
vectors targeting the same regions as the siRNAs were constructed in
a GFP-expressing shRNA vector (pRNA-U6.1, Genscript, USA).2.3. Puriﬁcation of retinal ganglion cells for primary cultures
Primary cell cultures were derived from 8 week-old rat retinas and
puriﬁed by modiﬁcations of the sequential immunopanning described
for young rats [21]. RGCs were resuspended in half Neurobasal® medi-
um (LifeTechnologies, Invitrogen) supplemented with B27 (1:50;
LifeTechnologies, Invitrogen) and L-glutamine (2 mM; LifeTechnologies,
Invitrogen) and half rat retinal cell-conditioned culture medium [22].
RGC were seeded at 25,000 cells/cm2 into 48-well tissue-culture plates
containing glass-coverslips previously coated 1 h with poly-D-lysine
(2 μg/cm2) and then with laminin 1 μg/cm2 overnight (both from
Sigma-Aldrich) [22]. siRNAs were added to the cells during the seeding
in plates. Cells were incubated at 37 °C in a humidiﬁed atmosphere of
5% CO2. Cells were counted with viability test at one and seven days
or ﬁxed before performing immunocytochemistry analyses. RGC
viability was assessed with the “live–dead” test (LifeTechnologies,
Invitrogen).2.4. In vivo electroporation
The electroporation (ELP) procedure was performed in only one
eye per rat essentially as described by Ishikawa and colleagues [19].
Under anesthesia with isoﬂurane (40 mg/kg body weight), 20 μg of
shRNA expression vectors was injected into the vitreous body, next
we proceeded to the ELP [20]. All the animals were euthanized
12 weeks after ELP.
2.5. Fundus imaging by confocal Scanning Laser Ophthalmoscopy
A digital cSLO (Heidelberg Engineering, Germany) with green laser
illumination was used to examine nerve ﬁber layer (NFL) in each
cardinal area of rat eyes before treatment and every three weeks
until euthanasia. Pupil dilation was performed with topical 1%
tropicamide (CibaVision, France). Rats were manually held in front of
the apparatus, in an upright position. The built-in software was used
for post-processing the images, including alignment, adjustment of
contrast, construction of a composite image [23].
2.6. Optomotor tests
The head-tracking method is based on an optomotor test devised
by Cowey and Franzini in 1979 and frequently used since then in
both rats and mice [24,25,20,26]. Long Evans rats were placed
individually on an elevated horizontal platform surrounded by a
motorized drum.
The protocol used yields independent measures of the acuities of
right and left eyes based on the unequal sensitivities of the two
eyes to pattern rotation: right and left eyes are most sensitive to
counterclockwise and clockwise rotations, respectively. A single
blinded operator conducted all assessments, and codes were broken
upon completion of data acquisition. The operator waited for the
animal to settle in the chamber before initiating drum rotation.
Vertical black-and-white lines of three varying widths, subtending
0.125, 0.25, and 0.5 cycles/degree (cyc/deg) were presented to the
animal and rotated alternatively clockwise and counterclockwise,
each for 60 s. This stimulated a subcortical reﬂex, so that a seeing
animal involuntarily turned its head to track the moving lines. Head
movements were recorded with a video camera mounted above the
apparatus. Animals were scored only when the speed of the head
turn corresponded to the speed of rotation of the stripes (12°/s).
Light levels were kept constant (240 lx). Each animal was tested at
four different time points by a single observer. During the experi-
ments, a second masked grader re-evaluated the recorded videos to
conﬁrm the reliability of the scoring system.
2.7. Retinal and optic nerve histology
Retinas or optic nerves were ﬁxed in 4% PFA at 4 °C, cryoprotected
by overnight incubation in PBS containing 30% sucrose at 4 °C. Retinas
were embedded in OCT (Neg 50; Richard-Allan Scientiﬁc) and frozen
in liquid nitrogen. Optic nerves were incubated in a 7.5% gelatin solu-
tion from porcine skin; Type A (Sigma-Aldrich) and 10% sucrose and
frozen in 2-methyl-butane solution. Sections of retinas and optic
nerves with a thickness of 10 μm were cut on a cryostat (Microm
Microtech) and mounted on SuperFrost Plus slides.
For immunochemistry, retinal sections were rinsed with PBS and
treated with 1% BSA, 0.1% Triton and 0.05% Tween 20 in PBS for 1 h.
They were then incubated with primary antibody overnight at 4 °C.
Sections were washed in PBS and incubated with the appropriate sec-
ondary antibodies and DAPI (2 μg/mL) for 2 h at room temperature.
Primary and secondary antibodies used are shown in Table S1. For
retinal ﬂat mounts, we followed the protocol described by Paques
and colleagues [27].
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Fluorescence labeling was monitored with: (i) a confocal laser
scanning microscope (Olympus FV1000). Microscope control and
image acquisition were conducted by using Olympus Fluoview®
software version 3.1. (ii) Retinal sections were also scanned with
the Hamamatsu Nanozoomer Digital Pathology (NDP) 2.0 HT, its
ﬂuorescence unit option (L11600-05) and the NanoZoomer's
3-CCD TDI camera (Hamamatsu Photonics, France). BRN3A-
positive cells, as the estimation of overall RGCs, were assessed for
each animal by manually counting three entire retinal sections as
described earlier [28]. A resolution of 0.23 μm per pixel (40×)
was used routinely. Finally, all the images were analyzed with
Photoshop and Image J.
2.9. RNA extraction and qRT-PCR assay
Total RNA from rat retinas were extracted using RNeasy Plus
Mini kit from Qiagen. One microgram of total RNA was reverse-
transcribed with oligo-dT using Superscript® II Reverse Transcrip-
tase (LifeTechnologies, Invitrogen) following the manufacturer's
instructions. NGB, Cytoglobin (CYGB), BRN3A, gamma-synuclein
(SNCG) and ATP6 primers were customized to be speciﬁc for each
mRNA species (Table S2) and synthesized by Invitrogen. Quantita-
tive PCR reactions were performed using ABI 7500 Fast (Applied
Biosystems). The equivalent of 10 ng and 2 ng of cDNAs (relative
to the whole RNA amount used for the reverse transcription) were
used per gene as template for qPCR reactions with Power Sybr®
green PCR Master Mix (Applied Biosystems) as recommended by
the manufacturer. Each biological sample was subjected to the
assay in triplicates per gene. Ct values were obtained by using ABI
7500 software (v.2.0.4) and the mitochondrial ATP6 gene was
selected to normalize in order to obtain relative mRNA amount
quantiﬁcations of each studied gene.
2.10. Mitochondrial puriﬁcation and western blotting analysis
24 retinas were isolated from 8 week-old rats and washed in PBS
at 4 °C; they were then homogenized in extraction buffer (0.32 M
sucrose, 30 mM Tris–HCl; pH 7.6, 5 mM MgAc, 100 mM KCl, 0.1%
fatty acid-free BSA, 5 mM β-mercaptoethanol, and 1 mM PMFS) and
mitochondria were puriﬁed as previously described [29] and as illus-
trated in Fig. S1. 30 μg of mitochondrial proteins was treated with 150
or 200 μg/mL PK in the presence or absence of 1% Triton X-100 (v/v)
at 4 °C for 30 min. The reaction was stopped by addition of 1 mM
PMFS (Sigma-Aldrich). Samples were collected by centrifugation at
10,000 g for 15 min at 4 °C. For mitoplast preparation, aliquots of
30 μg of mitochondrial pellets (in 100 μL of extraction buffer) were
subjected to osmotic shock by addition of 900 μL of 3 mM HEPES
(pH 7.4) containing 1 mM of PMFS. After incubation on ice for
15 min, the suspension was centrifuged at 10,000 g for 15 min to
yield the mitoplast pellet. All the samples were then resolved in 12%
or 15% SDS-PAGE and next transferred to a PVDF membrane.
Membranes were probed with antibodies against Ngb, ATP
synthase-α and TOMM20 (cf. Table S1). Immunoreactive bands
were visualized with anti-mouse or anti-chicken coupled to horse-
radish peroxidase (0.1 mg/mL) followed by ECL Plus detection
(Amersham International). Five independent mitochondria puriﬁca-
tions were subjected to the analyses.
2.11. Tissue homogenate preparation and respiratory chain enzymatic
assays
Optic nerves were prepared at 4 °C by homogenization of tissues
using a 1 mL hand-driven glass–glass potter in 100 μL of extraction
buffer (0.25 mM sucrose, 40 mM KCl, 2 mM EGTA, 1 mg/mL BSA,and 20 mM Tris–HCl, pH 7.2). Large cellular debris were spun down
by a low speed centrifugation (1000 g×8 min) and supernatants
were used immediately. Respiratory chain complex activities were
measured using a Cary 50 spectrophotometer maintained at 37 °C
(Varian, Australia) as previously described [30]. Each assay was
made in duplicate with 20 μL of the homogenates obtained. Complex
activity values were converted to speciﬁc activities after protein
quantiﬁcation by the Bradford method. All chemicals were of the
highest grade from Sigma Chemical Company.
2.12. Statistical analyses
Values are expressed as means±SEM (standard error of the mean).
Statistical analyses were performed with the GraphPad Prism5.0
software assuming a conﬁdence interval of 95%. Data collected for
all the independent observations were compared using the non para-
metric signiﬁcance test of Mann–Whitney U (*≤0.05, **≤0.01 and
***≤0.005).
3. Results
3.1. Neuroglobin proﬁles in adult rat retinas
RGC integrity is essential for visual function and its loss is directly
involved in optic neuropathies and glaucoma [31,32]. In an attempt to
relate Ngb and mitochondria we compared the subcellular distribu-
tion of the mitochondrial protein ATP synthase-β (a subunit of the
respiratory chain complex V) and the Ngb protein by immunostaining
of retinal sections. Consistent with other reports [33,14,16], cells pos-
itive for antibodies against Ngb were found in the photoreceptor layer
(PL), the inner nuclear layer (INL) and the GCL (Fig. 1A). It clearly
appeared that Ngb is highly expressed in RGCs, speciﬁcally labeled
with an antibody against the transcription factor BRN3A [34]. To fur-
ther support the presence of Ngb in RGCs and its possible localization
to mitochondria, we examined retinal ﬂat mounts and optic nerve
sections from adult rats processed for immunohistochemistry
using anti-Ngb associated to anti ATP synthase-β (Fig. 1B and C).
Immunolabeled RGCs showed a cytoplasmic, a dendritic, and an
axonal distribution of Ngb protein. The immunoreactivity of the Ngb
antibody was often revealed as a punctuate distribution of ﬂuorescent
dots excluded from the nuclei, similar to the signal obtained with
anti-ATP synthase-β antibody; both antibodies revealed an elevated
extent of colocalization (Fig. 1B and C). Moreover, Fig. 1C (top
panel) clearly shows a homogenous signal of Ngb in RGC somas and
their dendrites in the IPL as well as in their axons in the Nerve Fiber
Layer (NFL). We also performed longitudinal optic nerve sections
from adult rats and processed them for immunohistochemistry
using anti-Ngb associated with anti-ATP synthase-β. Ngb signals
observed in optic nerves not only overlapped with ATP synthase-β
signals but also conﬁrmed the presence of mitochondrial labeling of
RGC axons which can be distinguished from that of the resident
optic nerve cells (Fig. 1C, bottom panel). Consequently, Ngb subcellu-
lar localization matches to some extent with the pattern of mitochon-
drial network revealed by ATP synthase-β in both RGC bodies and
their axons.
3.2. Neuroglobin subcellular localization in retinal neurons
To ascertain whether Ngb can be detected inside the mitochon-
dria, organelle fractions puriﬁed by differential centrifugation
(Fig. S1) from rat retinas were subjected to immunoblot analyses.
Fig. 2A shows that speciﬁc antibodies against Ngb recognized three
proteins of ~17, ~19 and ~21 kDa apparent molecular mass, in
enriched mitochondria fractions; only the 17 kDa form was found in
the cytosol. To compare the proportion of Ngb in the cytosol or the
mitochondria relative to the total amount of Ngb in homogenates
Fig. 1. Immunostaining of neuroglobin in rat retinas. The cellular and subcellular localization of Ngb and mitochondria was examined by indirect immunoﬂuorescence in retinal
sections (A and C), retinal ﬂat mounts (B) or optic nerves (C) using either monoclonal or polyclonal antibodies against Ngb (green), or ATP synthase-β (red) (Table S1). BRN3A
immunostaining has been reported as a reliable and simple method for identifying RGCs in retinal cross section and ﬂat mounts. The subcellular distribution of the mitochondria
has been reported with the ATP synthase β antibody in different parts of rat retinas, especially in GCL and in nerve ﬁbers of the optic nerve. The scale bar represents 100 μm and
20 μm in magniﬁcation in (A), 25 μm in (B) and 50 μm in (C); images were obtained with confocal laser scanning microscope Olympus FV1000. Abbreviations: PL, photoreceptor
layer, ONL, outer nuclear layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer; NFL, nerve ﬁber layer; ON, optic nerve.
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Fig. 1 (continued).
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dent experiments of subcellular fractionation as described in Fig. S1.
The results are illustrated in Fig. S2 and indicate that: (i) signals
obtained with antibody against Ngb or ATP synthase αwere enriched
in mitochondrial fractions relative to whole homogenates or cytosols;
(ii) when the sum of the Ngb signals in mitochondrial and cytosolic
factions were calculated it appears that approximately 70% of the
overall Ngb signal was revealed in the mitochondrial compartment.
To further evaluate if Ngb was completely translocated inside the
organelle, mitochondria fractions were treated with proteinase
K (PK); signiﬁcant amounts of the three forms of Ngb and ATP
synthase-α are insensitive to PK-induced proteolysis, thus indicating
that Ngb forms were truly integrated into the mitochondria and
hence remain detectable on immunoblotting (Fig. 2B). Next, we treated
mitochondrial fractions with PK and Triton X-100; theoretically the
detergent disrupts both mitochondrial membranes and leads to the
entire proteolysis of mitochondrial proteins demonstrating their
localization inside the organelle in a protease-sensitive form. Fig. 2B
clearly shows that ATP synthase-α and Ngb protein signals became
diminished as they were digested by PK in the presence of the
detergent.
To determine whether Ngb could be present either in the
intermembrane space or the internal side of the inner membrane;
mitoplasts were obtained by subjecting the samples to osmotic
shock. The outer membrane protein TOMM20 was signiﬁcantly
digested by proteinase K, as expected since a portion of it is exposed
to the cytosolic side, moreover the signal entirely disappeared in
mitoplasts. By contrast, the three forms of Ngb were mostly preserved
as is ATP synthase-α Fig. 2C). Hence, the three forms of Ngb identiﬁed
by western blotting of mitochondrial fractions were fully integrated
inside the organelle and they could be further contained in the matrix
or in the matrix side of the inner membrane.3.3. Neuroglobin knockdown in rat puriﬁed primary culture of retinal
ganglion cells by small interfering RNA
We examined whether the inhibition of NGB expression inﬂuenced
RGC survival and neurite outgrowth in primary RGC cultures via the
small interfering RNA (siRNA) strategy.
To study the impact of NGB knockdown on cell survival and neurite
outgrowth, the anti-Ngb siRNA or the scrambled siRNA was associated
with transfection agent and added on the 1st day of RGC cultures in rat
retinal cell-conditioned medium [22]. Under this culture condition
RGCs survive 7–12 days and developed neuritic processes that may ex-
tend for several cell-body diameters and were often branched [20] as
shown in Fig. 3A. After seven days of culture, many viable cells develop
neuritic processes and immunoreactivity obtained with the antibody
against Ngb was similar to that observed with the antibody against
the mitochondrial ATP synthase-β polypeptide, as previously observed
in vivo (Fig. 1B). Indeed, both proteins were distributed along the
neuritic processes and in the cytosol of RGC primary culture in control
conditions (Fig. 3A). Furthermore, it clearly appears that Ngb immuno-
staining was strongly reduced (Fig. 3A) compared to cells transfected
with scrambled siRNA or untreated cells.
Cell survival was assessed by counting live RGCs from dead-cell
population. In controls, we observed an approximate 50% diminution
in the total amount of living cells after 7 days of culture, an expected
phenomenon related to the vulnerability of these adult neurons once
their axons are disrupted. In fact, previous reports described that after
10 days of culture, the cell density was reduced to 10% in control con-
ditions and to 30% when conditioned medium obtained from retinal
cells was used [22]. Despite this effect, we observed a signiﬁcant
and more pronounced decrease (~3-fold) in cell survival when
RGCs were transfected with anti-Ngb siRNA (Fig. 3B) relative to either
control conditions or scrambled siRNA treatment. The differences
Fig. 2. Neuroglobin presence in puriﬁed mitochondria. (A) Western blot detection of
Ngb and ATP synthase-α proteins in the different subcellular fractions (30 μg of pro-
tein/lane were tested). Three Ngb forms of apparent molecular mass of ~17, ~19 and
~21 kDa were detected in enriched mitochondrial fractions (n=5). (B) A protein
which is not entirely translocated inside the organelle is accessible to PK proteolysis
and subsequently becomes undetectable. 30 μg of mitochondrial extracts was treated
with 150 or 200 μg/mL of PK in the presence or absence of 1% Triton X100 at 4 °C for
30 min. Samples were then collected by centrifugation at 10,000 g for 15 min at 4 °C.
(C) Mitochondria subjected to PK digestion (150 μg/mL) in the presence or absence
of Triton X-100 as well as mitoplast pellets were subjected to western blot analysis
as in Fig. 2B and C. Changing ratio of the three Ngb forms was detected between
independent mitochondrial fractions and can be explained by different proportion of
protein structural state or post-translational modiﬁcation. The western blots were
examined with two different commercial anti-Ngb antibodies.
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(p: 0.0007 or 0.02 respectively). This result indicates that NGB
expression is essential for RGC survival in vitro.3.4. In vivo knockdown of neuroglobin expression in retinal ganglion cells
of adult rats and its impact on nerve ﬁber density
The impact of NGB expression attenuation was assessed in vivo by
ELP [19,20], after injection in the vitreous body of one eye of a plas-
mid DNA leading to the synthesis of a short hairpin RNA (shRNA)
anti-Ngb. The in vivo ELP procedure results in a highly efﬁcient gene
delivery to the GCL since more than 50% of RGCs express the trans-
gene for at least 2 months [20]. NFL integrity was evaluated using
confocal Scanning Laser Ophthalmoscopy (cSLO), which represents
a powerful technique for in vivo imaging of rodents eye fundus
[28,26]. Striations of NFL radiating from the optic disc were clearly
visible in each eye from rats subjected to ELP. Each area of the eye
fundus was visualized before and at different times after treatment
until euthanasia. Fig. 4 shows nerve ﬁber density before and
3 months after scrambled shRNA plasmid administration (rat #4):
eye fundus visualizations did not show any darker or thinner stria-
tions, when compared to the ones obtained before ELP or to untreated
eyes (Control). In contrast, a noticeable loss of nerve ﬁber bundles
was evidenced in eyes electroporated with anti-Ngb shRNA: images
collected for three rats are shown in Fig. 4 (rat #1, #2 and #3). The
NFL striation loss, especially in the S and I areas, reﬂects RGC axon
degeneration and was noticed one month after the ELP. Nerve ﬁber
disappearance was observed in ~25% of treated anti-Ngb shRNA
eyes (n=24); while eye fundus from all the eyes electroporated
with the scrambled shRNA plasmid (n=22) or untreated eyes (n=
46) showed well preserved tracks of axons in all the areas visualized
until euthanasia (Fig. 4). These results indicated that RGC axons in the
NFL of treated anti-Ngb shRNA eyes have undergone a degenerative
process, conﬁrming the deleterious effect of in vivo NGB knockdown.
3.5. Relative abundance of neuroglobin and speciﬁc retinal ganglion cells
mRNAs
To substantiate that the anti-Ngb shRNA treatment was efﬁcient in
reducing NGB mRNA levels, its abundance in retinas was determined
by quantitative real-time PCR of reverse-transcribed mRNAs
(RT-qPCR) using the comparative ΔΔCt method and the mitochondri-
al ATP6 gene as “normalizing” gene. RNA preparations from retinas of
18 control eyes, 8 eyes treated with scrambled shRNA or 10 eyes
treated with anti-Ngb shRNA, from rats euthanized 3 months after
ELP, were examined. The relative amount of NGB mRNA in anti-Ngb
shRNA-treated retinas was 13.8% less abundant than in retinas isolat-
ed from the 18 untreated eyes; this difference was signiﬁcant
according to the Mann–Whitney test (p=0.023) (Fig. 5A). The de-
crease of NGB mRNA may appear small, but RNAs were prepared
from the whole retinal cell population. Thus, NGB mRNA levels of
RGCs transduced with the anti-Ngb shRNA cannot be discriminated
from those of untransduced cells which also expressed NGB (bipolar
and photoreceptor (Fig. 1A), whose proportion is very high relative
to RGCs; indeed, the fraction of RGCs relative to the total cell popula-
tion was estimated at less than 1% in adult mouse retina [35]. The ad-
ministration of the plasmid directing the synthesis of scrambled
shRNA did not change the relative abundance of NGBmRNA in treated
retinas compared to retinas from untreated eyes (p=0.51) (Fig. 5A).
Additionally, we evaluated the relative amount of CYGB mRNA
encoding another hexacoordinated globin [36]; it did not change in
any of the retinas examined (p=0.87 and 0.22 for scrambled and
anti-Ngb shRNA respectively) conﬁrming that anti-Ngb shRNA plas-
mid administration leads speciﬁcally to the diminution of NGB
mRNA steady-state levels (Fig. 5A).
We also measured the amount of SNCG and BRN3A mRNAs since
they are highly abundant in adult RGCs [37,38], while they are almost
undetectable in other retinal neurons [39]. Anti-Ngb shRNA-treated
eyes showed a ~20% reduction of both SNCG and BRN3AmRNA levels
relative to values measured in retinas from control eyes (p=0.002
Fig. 3. Impact of neuroglobin knockdown on retinal ganglion cells survival in primary cultures. (A) After 7 days of culture, cells were visualized by indirect immunoﬂuorescence
with antibodies against Ngb or ATP synthase-β. RGCs were labeled essentially within their cytosol; a clear difference of labeling was noticed between cells transfected with
Ngb-siRNA and those transfected with scrambled-siRNA as well as cells cultured in control conditions. The scale bar represents 20 μm. (B) Cell survival was estimated using the
“live–dead” test. Only alive RGCs were counted from ten ﬁelds selected identically on each coverslip of three independent RGC cultures at one or seven days. Results were presented
as cell survival relative to control conditions (mean values±S.E.M, standard error for the mean).
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steady-state levels of SNCG and BRN3A mRNAs did not change in
eyes electroporated with the scrambled shRNA relative to controls:
p=0.17 and 0.95 for SNCG and BRN3A respectively (Fig. 5B). Thus,
NGB knockdown was effective in reducing NGBmRNA level which re-
sults in a ~20% reduction of SNCG and BRN3A mRNA amounts. This
diminution could reﬂect RGC loss, since SNCG or BRN3A expression
is considered as an index of RGC number [40].
3.6. Deleterious effect of neuroglobin knockdown on retinal ganglion cells
integrity in vivo
To corroborate the negative impact of NGB knockdown on RGC in-
tegrity, we examined retinal sections from rats euthanized 3 monthsafter the treatment by immunochemistry using antibodies against
Ngb and BRN3A proteins. Retinal sections of anti-Ngb shRNA-treated
animals presenting a noticeably loss of nerve ﬁbers (Fig. 4) showed an
important diminution of BRN3A-postive cells and the Ngb immuno-
staining signal in the GCL relative to the signals observed in the
accompanying untreated eye (Fig. 6A rat #1); an additional rat retinal
section is shown in which a more subtle reduction of BRN3A-postive
cells was evidenced (Fig. 6A rat #5). Ngb staining in the other retinal
layers was similar in treated and control eyes (Fig. 6A rat #1 and #5).
On the other hand, no evident changes in BRN3A-positive cells were
noticed in eyes electroporated with scrambled shRNA (Fig. 6A rat
#4). Cryostat sections of retinas were counted for BRN3A-positive
cells in the GCL to estimate the number of RGCs in 8 eyes
electroporated with anti-Ngb shRNA, 7 eyes electroporated with
Fig. 4. Nerve ﬁber layer visualizations using confocal Scanning Laser Ophthalmoscope.
Each area (N: nasal, T: temporal, I: inferior, S: superior) of the eye fundus was
visualized by cSLO imaging. Eyes from rats #1, #2 and #3 treated with anti-Ngb
shRNA plasmid exhibited a manifest diminution of optic ﬁber density 12 weeks after
the treatment (yellow dashed line). No RGC axons loss was noticed in rats #4 subjected
to scrambled shRNA plasmid DNA administration. Additionally, cSLO images of the
corresponding untreated eyes revealed no changes in RGC axon density.
Fig. 5. In vivo impact of neuroglobin down regulation. RT-qPCR assays were performed
with total RNAs from retinas (isolated from rats 3 months after the ELP) to determine
the steady-state levels of NGB and CYGB (A), SNCG and BRN3A (B) mRNAs. 18 control
eyes, 8 eyes treated with scrambled shRNA and 10 eyes treated with anti-Ngb shRNA
were evaluated (mean±S.E.M presented). Relative fold variations were calculated
using the comparative ΔΔCt method and the mitochondrial ATP6 gene as a normalizing
gene. Primers used for each gene are shown in Table S2.
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(overall number of RGCs /mm) was reduced in anti-Ngb shRNA-
treated retinas relative to control retinas (Fig. 6B), the diminution of
about 20% was signiﬁcant according to the Mann–Whitney t test:
p=0.001. Conversely, RGC density in eyes treated with scrambled
shRNA was not signiﬁcantly different to controls: p=0.25 (Fig. 6B).
Hence, in vivo ELP with anti-Ngb shRNA leads to a signiﬁcant RGC
loss which supports the optic ﬁber disappearance evidenced by eye
fundus imaging (Fig. 4).
3.7. Impact of neuroglobin knockdown on respiratory chain activity in
optic nerves
Since the number of BRN3A-positive cells and eye fundus imaging
indicated that the knockdown of NGB expression leads to RGC degen-
eration, we evaluated whether respiratory chain function can be
hampered in optic nerves isolated from animals sacriﬁced 3 months
after anti-Ngb shRNA treatment. The spectrophotometric method
used for assessing enzymatic activities of respiratory chain complexes
has been successfully applied to accurately detect isolated defects in
small amounts of tissue homogenates [30,28]. Two independent spec-
trophotometric assays were devised [30] to sequentially measure in
homogenates of single optic nerves the enzymatic activities of:(1) rotenone-sensitive complex I (CI) and oligomycin-sensitive com-
plex V (CV); (2) complex IV (CIV), malonate-sensitive combined
complex II+III (CII+CIII) and antimycin-sensitive complex III (CIII)
(Fig. 7A). A 30% decrease relative to control values was observed for
CI and CIII speciﬁc activities in optic nerves of eyes electroporated
with anti-Ngb shRNA (n=17) relative to control optic nerves (n=
32); the differences were signiﬁcant according to the Mann–Whitney
test; p values were 0.001 and 0.051 for CI and CIII activities respec-
tively (Fig. 7B). Conversely, CI and CIII activities in optic nerves from
eyes electroporated with scrambled shRNA (n=15) were not signif-
icantly different from those measured in untreated eyes (p values:
0.64 and 0.63 respectively). Besides, CII, CIV and CV activities were
similar between anti-shRNA-treated eyes and controls (Fig. 7B).
Thus, NGB knockdown in retinas interferes in a speciﬁc manner on
respiratory chain function in optic nerves, since the defect was
speciﬁcally demonstrated in CI and CIII enzymatic activities.
3.8. Functional assessment of visual responses in animals treated with
anti-Ngb shRNA
The functional consequences of RGC loss due to anti-Ngb shRNA
treatment on visual function was assessed by optomotor head-
tracking experiments [24,25]. Tracking capability was examined
in both clockwise and counterclockwise drum rotations at three
frequencies: 0.5, 0.25 and 0.125 cycles per degree. Because only
temporal-to-nasal motion is effective through each eye, clockwise
movement will drive tracking through the left eye, whereas counter-
clockwise motion will activate the right eye [25]. Fig. 8A shows visual
Fig. 6. Neuroglobin knockdown leads to RGC loss. (A) In vivo effect of anti-Ngb shRNA on RGC viability was assessed by immunostaining for BRN3A and Ngb antibodies of retinal
sections obtained from rats euthanized 3 months after the ELP. Decrease of Ngb (green) and BRN3A (red) signals in the GCL was only noticed in the anti-Ngb shRNA-treated group,
whereas Ngb staining did not change between treated and control conditions in the other retinal cell layers. The scale bar represents 100 μm. (B) RGC densities were calculated after
immunolabeling for BRN3A antibody and DAPI staining; this later allowing estimation of total nuclei in the GCL. BRN3A and DAPI-positive cells in the GCL were counted in three
independent retinal sections per animal: 10 control eyes, 7 eyes treated with scrambled shRNA and 8 eyes treated with anti-Ngb shRNA. Results were presented as cell density/mm
relative to control conditions (mean values±S.E.M, standard error for the mean, student t test).
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10); they mostly presented head tracking scores of similar magnitude
for the clockwise or counterclockwise drum rotations. Fig. 8B shows
data collected from rats 10 weeks after the treatment with scrambled
shRNA or anti-Ngb shRNA plasmid. Rats treated with scrambled
shRNA (n=20) showed no signiﬁcant difference between clockwise
and counterclockwise responses for all the three spatial frequencies
tested (0.125 p=0.30 at 0.125 cycles per degree, p=0.94 at 0.25,
and p=0.68 at 0.5. Moreover, their clockwise responses before plas-
mid administration and 10 weeks later were very similar for instance
for the 0.5 cycle per degree frequency the p value calculated was 0.41(Fig. 8A, untreated 8 week-old and Fig. 8B scrambled shRNA) (Movie
S1). Conversely, we measured an unequivocal decline in visual per-
formance in rats treated with anti-Ngb shRNA (n=22) which
responded with poor clockwise scores; indeed they spent much less
time tracking across the test period for the clockwise drum rotation
relative to the counterclockwise responses. The decline in visual
performance was statistically different (pb0.0001 at all three
frequencies); which represents a 46% decrease of that measured for
their accompanying control eyes (Fig. 8) (Movie S1). Obviously
when the clockwise responses of these animals were compared to
the one collected from untreated animals of 18 week-old (Fig. 8A,
Fig. 7. Detection of respiratory chain complex activities in optic nerves. (A) Illustrative curve for the successive measurements of complex I (EC 1.6.5.3) and complex V activities (EC
3.6.3.14); complex IV (CIV) (EC 1.9.3.1), complex II+III (CII+CIII) (EC 1.3.2.2) and complex III (CIII) (EC 1.10.2.2). (B) Speciﬁc activities assessed in optic nerves from 32 control
eyes, 17 eyes treated with anti-Ngb shRNA or 15 treated with scrambled shRNA are shown. Abbreviations: CI–CV, various complexes of the respiratory chain; Aa, antimycin A; ATP,
adenosine triphosphate; Cyt, cytochrome; DCPIP, dichlorophenol indophenol; DQ, DQH2, duroquinone (oxidized), duroquinol (reduced), respectively; EDTA, ethylene diamine
tetraacetic acid; KCN, potassium cyanide; LDH, lactate dehydrogenase; MgCl2, magnesium chloride; NADH, reduced nicotinamide adenine dinucleotide; oligo, oligomycin;
ox, oxidized; PEP, phosphoenol pyruvate; PK, pyruvate kinase; red, reduced; rot, rotenone; succ, succinate.
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cant (pb0.005 at all three frequencies). Thus, RGC loss due to NGB
knockdown has a negative impact on head-tracking behavior;
indicating the direct connection between NGB expression, respiratory
chain function and visual function.
4. Discussion
The evidence linking Ngb and mitochondrial function has in-
creased in the last few years [41–43,13,44]. Several authors found
Ngb in close association with mitochondria using immunohistological
[45,13] or electron microscopy studies [12]. Recently, Ngb was phys-
ically localized inside the organelle under physiological conditions
and NGB overexpression was correlated with increasedmitochondrial
distribution of Ngb in cultured neuronal cells [44]. Additionally, po-
tential Ngb-partners have been identiﬁed and some of them areknown mitochondrial proteins such as ATP synthase-β, cytochrome
c1, and the electron-transferring ﬂavoprotein α subunit (Etfα) [43].
In a recent report, we showed that Ngb is a highly abundant protein
in rat retinas, especially in the GCL, INL and PL [16] which are the
main sites of oxygen consumption [46,45]. The GCL is composed of
>40% of RGC [35], the rest being displaced amacrine cells, astrocytes
and the end-feet of Müller cells; we conﬁrmed here that RGCs possess
high levels of Ngb and it clearly appeared that in these cells the
cytoplasmic and neuritic distribution of Ngb and the mitochondrial
protein ATP synthase-β largely overlapped (Fig. 1).
Furthermore, we provide biochemical proof of the mitochondrial
Ngb localization in rat retinas by subjecting subcellular fractions to
immunoblotting analyses. Three forms of apparent molecular masses
of ~17, ~19 and ~21 kDa, speciﬁcally recognized by anti-Ngb anti-
bodies, were identiﬁed in mitochondrial enriched fractions. Cytosolic
fractions revealed only the 17 kDa form and sometimes the
Fig. 8. Assessment of visual performance after neuroglobin knockdown. Four different
groups of rats were evaluated for head tracking movements at an angular speed iden-
tical to that of the drum rotation: (A) 22 animals 8 week-old (before the ELP) and 10
control rats 18 week-old. No signiﬁcant difference was measured in the three grating
frequencies monitored in any of the animals examined in both clockwise and counter-
clockwise directions of motion. (B) 22 rats treated with anti-Ngb shRNA, 20 rats treat-
ed with scrambled shRNA. An unequivocal and signiﬁcant decline in visual
performance was measured in rats treated with anti-Ngb shRNA which responded
with poor clockwise scores. Rats treated with scrambled shRNA showed no signiﬁcant
difference between clockwise and counterclockwise responses. Mean values±S.E.M
are presented.
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17 kDa form of Ngb form is the one that up to date has been described
in mouse and bovine retinas [47]. The Ngb forms detected in mito-
chondria were insensitive to PK-proteolysis, strengthening the notion
that they were fully translocated into the organelle and that they are
located either in close vicinity to the inner membrane or inside the
matrix since mitoplasts (mitochondria devoid of outer membrane
and the intermembrane space) preserved intact the three Ngb forms
(Fig. 2). By using different software's for peptide signal prediction
(MITOPROT, PSORT and TargetP), we were unable to identify a char-
acteristic amino-terminal presequence in Ngb. This indicates that
Ngb does not use the import pathway guided by amino-terminal
presequences (concerning ~50% of mitochondrial proteins) which
involves TOMM20, TOMM22 and TOMM40 [48]. Hence, Ngb as the
majority of noncleavable precursor proteins may contain quite
distinct targeting signals at various positions within its primary
structure [49]. Recently, it has been shown in primary-cultured
mouse cortical neurons that less than 10% of total Ngb is physically
located in the mitochondria and that its abundance within the organ-
elle increased after oxygen-glucose deprivation [44]. In rat retinas, we
demonstrated that enrichment of Ngb in the organelle was signiﬁ-
cant, with the overall signal for the three forms of about 70% relative
to the abundance of the 17 kDa cytosolic form (Fig. S1). The question
arises of the nature of these three forms of Ngb detected inmitochondrial fractions; they could represent atypical migrations of
different stable protein conformations. Interestingly, whole proteins
extracts from mouse brain and retinas subjected to SDS PAGE and
western blotting display a Ngb signal of ~17 kDa and a second band
of about 34 kDa which likely results from the dimerization of Ngb,
as if the disulﬁde-linked dimer was resistant to heat denaturation
and DTT reduction [47]. Hence we hypothesize that rupture/
formation of the intra molecular (CD7-B5) disulﬁde bond [50]
can give rise to different apparent molecular mass forms. Post-
translational modiﬁcation of the 17 kDa form could also occur such
as covalent links of cofactors or phosphorylation; this latter was
recently observed for globins in different species [51].
Optic neuropathies with mitochondrial etiology are characterized
by selective death of RGCs and optic nerve atrophy leading to central
vision loss due to severe oxidative phosphorylation defect [31,52,17].
Hence, we addressed the question of whether NGB knockdown could
have deleterious effects on RGC integrity. We successfully obtained a
knockdown of NGB expression level using the siRNA technique and
demonstrated that endogenous Ngb was essential for RGC survival
in vitro. Moreover, the injection in the vitreous body of an anti-Ngb
shRNA plasmid followed by ELP let to an efﬁcient knockdown of
NGB expression in RGCs. 3–4 weeks after the treatment, RGC soma
and axons degenerated, which engendered a signiﬁcant diminution
of respiratory chain complex I and III activities (Fig. 7) and certainly
contributed to visual function impairment (Fig. 8).
In 2009, studies performed with primary cortical neurons isolated
from a NGB overexpressing transgenic mice showed that Ngb
promotes neuron survival by improving mitochondrial function and
reducing oxidative stress after hypoxic/reoxygenation insults [41].
While the cellular functions of Ngb remain to be elucidated at the
molecular level, our discovery that speciﬁc Ngb forms localize to
mitochondria helps to clarify Ngb's effects in mitochondrial function
and oxidative stress. Investigations of Ngb oxygen afﬁnity,
presupposing cellular oxygen tension values between 1 and a few
Torrs, suggests that in vivo Ngb is partially present in the ferrous
deoxy form [50]. A rapid electron transfer from ferrous Ngb to ferric
cytochrome c has been demonstrated in vitro with a recombinant
Ngb; the bimolecular rate of electron transfer was 1.5×107/M/s
close to the fastest known, for example between Cyt c and cyto-
chrome c oxidase; [53]. This thermodynamic process is favorable
since Ngb exhibits a redox potential (−129 mV) fully compatible
with electron transfer to cytochrome c which has a positive redox
potential (+260 mV) [54,55]. Hence, the prospect of electron ex-
changes between Ngb and Cyt c in vivo is reinforced with our data
that demonstrates the requirement of Ngb to ensure the respiratory
chain functionality in optic nerves.
Since RGC viability is strongly dependent on mitochondrial
robustness, the data presented here highlight the role of Ngb in pre-
serving organelle integrity by establishing its subcellular distribution
within the organelle and the dependency on Ngb of respiratory chain
complex I and III enzymatic activities. Since it has been recently
reported that Ngb has a neuroprotectant role against glaucomatous
damage [18], we hypothesize that NGB overexpression may
slow-down the process of retinal cell death in a broad range of oph-
thalmic conditions as shown in AD transgenic mice (APPSw,Ind)
[56]. In conclusion, we postulate that Ngb appears as a promising
candidate for preventing the degeneration of retinal neurons due to
mitochondrial dysfunction, such as optic neuropathies or glaucoma.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamcr.2012.09.009.
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